Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus—as well as metabolic diseases, immunology, and pain management.

Biotechnology

Health Care

Therapeutics

Bonum Therapeutics

Bonum Therapeutics' headquarters in Seattle, WA, United States

John Mulligan, Ph.D.

Rhonda Knudsen

Neela Patel

Diane Hollenbaugh

The Scientific Research and Development team at Bonum Therapeutics is responsible for advancing the company's technology platform to treat various diseases, with a primary focus on cancer. This team conducts cutting-edge research, develops new therapeutic approaches, and collaborates across disciplines to bring innovative treatments from the lab to clinical application.

Scientific Research and Development

The Leadership Team at Bonum Therapeutics is responsible for setting the company's strategic direction, overseeing research and development initiatives, and ensuring alignment of business and scientific goals. This team includes key executives and principal scientists who drive the innovation and commercialization of the company's technology platform to treat cancer and other serious diseases.

Leadership Team

This department provides strategic guidance and decision-making support to ensure the organization meets its objectives and adheres to regulatory standards.

Bonum Therapeutics

Org chart

Teams

Scientific Research and Development

Leadership Team

Governance and Oversight

Offices

Bonum Therapeutics

Org chart

Teams

Scientific Research and Development

Leadership Team

Governance and Oversight

Offices

Related companies